News

Hosted on MSN4mon

Araceli Biosciences raises $11.2M for imaging and AI analysis systems to help speed drug discovery

Portland-based biotech company Araceli Biosciences raised $11.2 million in new funding to fuel the expansion of its high-content imaging technology and AI-powered analysis used to speed drug discovery ...
Business Wire4mon

Slingshot Biosciences Debuts TruCytes™ Potency—Cell Mimics for Scalable, Reproducible CAR-T Potency Assays

EMERYVILLE, Calif.--(BUSINESS WIRE)--Slingshot Biosciences, the leader in precision-engineered cell mimic technologies, today announced the launch of TruCytes™ Potency, a new class of biomarker cell ...
Morningstar1mon

Alamar Biosciences and the German Center for Neurodegenerative Diseases (DZNE) partner for Landmark Proteomic Profiling study in the Rhineland Study Cohort

NULISAseq™ CNS Disease Panel 120 and Inflammation Panel 250 to Power Biomarker Discovery in 23,000 Longitudinal Samples FREMONT, Calif., July 29, 2025 /PRNewswire/ -- Alamar Biosciences, a company ...
Nasdaq3mon

SNAP Biosciences and Monarch Therapeutics Announce Licensing Agreement for Next-Generation NK Cell Therapy Development

SNAP Biosciences, a subsidiary of Coeptis Therapeutics Holdings, has entered into a licensing agreement with Monarch Therapeutics to develop and commercialize its Snap-Car NK cell therapy platform for ...